Introduction • Global transcriptomics market was valued at $3,212 million in 2016, and is projected to reach $7,954 million by 2023, growing at a CAGR of 13.8% from 2017 to 2023. • Transcriptomics is the study of entire set of RNA transcripts produced by the genome of any organism. Increase in advancements in the field of transcriptomics such as extensive use of RNA-sequencing and rise in application of transcriptomics, which includes drug discovery is expected to drive the growth of the transcriptomics market. • Thermo Fisher Scientific, Inc., initiated new Ion Torrent Transcriptome Profiling Grant Program, which focusses on the benefits of gene-level expression analysis as novel biomarkers, which can help in cancer diagnostics, prognostics, and experimental therapy use.
Drug discovery application led the overall transcriptomics market, and accounted for nearly three-fifths of the total market in 2016. • Sequencing technology is projected to grow at highest CAGR of 15.1% during the forecast period. • CROs are the fastest growing end user market for transcriptomics and are expected to witness CAGR of 14.1% during the forecast period. • qPCR technology segment occupied nearly half of the global transcriptomics market in 2016. • Japan is the major shareholder, accounting for more than one-third of the Asia-Pacific transcriptomics market in 2016. Key Findings of theMarket
The study provides an in-depth analysis of the global transcriptomics market, with current trends and future estimations to elucidate the imminent investment pockets. • Quantitative analysis from 2016 to 2023 is expected to enable the stakeholders to capitalize on prevailing market opportunities. • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities. • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework. Key Benefits Get Access to TOC / Sample Report @
By Technology • Real Time-PCR (qPCR) • Microarray • Sequencing • Sanger Sequencing • RNA-Sequencing • By Product & Services • Consumables • Instruments • Software • Services • By Application • Diagnostics & Disease Profiling • Drug Discovery • Others MarketSegmentation • End User • Government Institutes & Academic Centers • Pharmaceutical & Biotechnology Companies • Contract research Organizations (CROs) • By Region • North America • Europe • Asia-Pacific • LAMEA
QIAGEN (Exiqon), • ThermoFisher Scientific Inc., • Illumina, Inc., • Agilent Technologies, • GE Healthcare Dharmacon Inc., • Bio-Rad Laboratories, Inc., • Others Key Players of theMarket For purchase enquiry, visit @https://www.alliedmarketresearch.com/purchase-enquiry/2595
About Allied MarketResearch: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective marketdomain. ContactUs: 5933 NE Win Sivers Drive, #205, Portland, OR 97220, UnitedStates. Int'l: +1-503-894-6022 TollFree: +1-800-792-5285 Fax: +1-800-792-5285 Contact Allied MarketResearch
ThankYou! For MoreDetails Visit usat https://www.alliedmarketresearch.com/transcriptomics-market Follow UsOn: